LOGIN
Assessing efficacy of allogeneic, bone marrow-derived mesenchymal stem cells in knee OA treatment
May 2019
Assessing efficacy of allogeneic, bone marrow-derived mesenchymal stem cells in knee OA treatment
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:2
Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel): preclinical and clinical trial in osteoarthritis of the knee joint
Arthritis Res Ther. 2016 Dec 20;18(1):301.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
60 patients with Kellgren-Lawrence grade II-II knee osteoarthritis were randomized to one of five treatments: bone marrow--derived allogeneic mesenchymal stromal cell injection at either a 25, 50, 75, or 150 million cell dose, or placebo injection. At each dose level, randomization was conducted at a 2:1 ratio of intervention to placebo; therefore a total of 10 patients were administered at each d...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.